Cells (Mar 2019)

FM19G11-Loaded Gold Nanoparticles Enhance the Proliferation and Self-Renewal of Ependymal Stem Progenitor Cells Derived from ALS Mice

  • Stefania Marcuzzo,
  • Davide Isaia,
  • Silvia Bonanno,
  • Claudia Malacarne,
  • Paola Cavalcante,
  • Antonella Zacheo,
  • Valentino Laquintana,
  • Nunzio Denora,
  • Barbara Sanavio,
  • Elisa Salvati,
  • Patrizia Andreozzi,
  • Francesco Stellacci,
  • Silke Krol,
  • Maravillas Mellado-López,
  • Renato Mantegazza,
  • Victoria Moreno-Manzano,
  • Pia Bernasconi

DOI
https://doi.org/10.3390/cells8030279
Journal volume & issue
Vol. 8, no. 3
p. 279

Abstract

Read online

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons. In ALS mice, neurodegeneration is associated with the proliferative restorative attempts of ependymal stem progenitor cells (epSPCs) that normally lie in a quiescent in the spinal cord. Thus, modulation of the proliferation of epSPCs may represent a potential strategy to counteract neurodegeneration. Recent studies demonstrated that FM19G11, a hypoxia-inducible factor modulator, induces epSPC self-renewal and proliferation. The aim of the study was to investigate whether FM19G11-loaded gold nanoparticles (NPs) can affect self-renewal and proliferation processes in epSPCs isolated from G93A-SOD1 mice at disease onset. We discovered elevated levels of SOX2, OCT4, AKT1, and AKT3, key genes associated with pluripotency, self-renewal, and proliferation, in G93A-SOD1 epSPCs at the transcriptional and protein levels after treatment with FM19G11-loaded NPs. We also observed an increase in the levels of the mitochondrial uncoupling protein (UCP) gene in treated cells. FM19G11-loaded NPs treatment also affected the expression of the cell cycle-related microRNA (miR)-19a, along with its target gene PTEN, in G93A-SOD1 epSPCs. Overall our findings establish the significant impact of FM19G11-loaded NPs on the cellular pathways involved in self-renewal and proliferation in G93A-SOD1 epSPCs, thus providing an impetus to the design of novel tailored approaches to delay ALS disease progression.

Keywords